182 related articles for article (PubMed ID: 9785612)
1. Why patients with diabetes, hypertension and/or proteinuria are not on angiotensin converting enzyme inhibitors.
Gordian ME; Kelly J
Alaska Med; 1998; 40(3):51-4. PubMed ID: 9785612
[No Abstract] [Full Text] [Related]
2. [The treatment of diabetic nephropathy. The need for an early diagnosis].
Teruel Briones JL
Rev Clin Esp; 1999 Jan; 199(1):1-3. PubMed ID: 10089768
[No Abstract] [Full Text] [Related]
3. Reducing complications in type 2 diabetes.
Poirier SJ
Am Fam Physician; 1998 Mar; 57(6):1238-9. PubMed ID: 9531907
[No Abstract] [Full Text] [Related]
4. Diabetes and ACE inhibitors.
Boulton AJ; Gokal R
J Hum Hypertens; 1990 Oct; 4 Suppl 4():63-6; discussion 66-7. PubMed ID: 2283656
[No Abstract] [Full Text] [Related]
5. [Angiotensin converting enzyme inhibitors in the treatment of diabetes].
Smahelová A
Vnitr Lek; 2003 Dec; 49(12):948-51. PubMed ID: 15040161
[No Abstract] [Full Text] [Related]
6. [Angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy].
Sawicki PT; Mühlhäuser I; Berger M
Dtsch Med Wochenschr; 1994 Sep; 119(38):1298-9. PubMed ID: 7924925
[No Abstract] [Full Text] [Related]
7. Microvascular hemodynamics in hypertension and diabetes.
Tooke JE; Sandeman DD; Shore AC
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S51-3. PubMed ID: 1725043
[TBL] [Abstract][Full Text] [Related]
8. When to treat the hypertensive diabetic patient.
Fuller JH
J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
[No Abstract] [Full Text] [Related]
9. [Converting enzyme inhibitors in diabetes].
Marre M
Rev Prat; 1992 Dec; 42(20):2574-7. PubMed ID: 1299943
[TBL] [Abstract][Full Text] [Related]
10. Screening and treatment of diabetic renal disease.
Clement JD; Cottiero RA
Med Health R I; 1998 Nov; 81(11):348-9. PubMed ID: 15580788
[No Abstract] [Full Text] [Related]
11. The diabetic with renal impairment.
Tallis GA; Phillips PJ; Popplewell PY
Aust Fam Physician; 1997 Sep; 26(9):1091-2. PubMed ID: 9382724
[No Abstract] [Full Text] [Related]
12. [Nephropathy in type-1 diabetes].
Sawicki PT; Berger M
Dtsch Med Wochenschr; 1993 Mar; 118(9):319-21. PubMed ID: 8444117
[No Abstract] [Full Text] [Related]
13. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
Andersen NH; Mogensen CE
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
[No Abstract] [Full Text] [Related]
14. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
Harman-Boehm I
Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
[No Abstract] [Full Text] [Related]
16. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
Esnault V
Nephrol Ther; 2006 May; 2 Suppl 3():S193-6. PubMed ID: 17370850
[TBL] [Abstract][Full Text] [Related]
17. [Arterial hypertension and diabetes mellitus: value of converting enzyme inhibitors].
Passa P
Bull Acad Natl Med; 1988 Feb; 172(2):205-10. PubMed ID: 3042105
[No Abstract] [Full Text] [Related]
18. Practical problems in the management of hypertension in the diabetic patient.
O'Hare JP
J Diabetes Complications; 1996; 10(3):146-8. PubMed ID: 8807462
[No Abstract] [Full Text] [Related]
19. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
Ozturk S; Sar F; Bengi-Bozkurt O; Kazancioglu R
Kidney Blood Press Res; 2009; 32(4):268-75. PubMed ID: 19776644
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
Kuriyama S; Tomonari H; Abe A; Imasawa T; Hosoya T
Nephron; 2000 Dec; 86(4):529-30. PubMed ID: 11124615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
